Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-11-08
2005-11-08
Wax, Robert A. (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S254110, C435S320100, C435S325000, C536S023500
Reexamination Certificate
active
06962798
ABSTRACT:
The present invention relates to a novel cardiac-specific transcription factor, myocardin. This molecule modulates the development and differentiation of cardiomyocytes and is a potent inhibitor of cell growth. Methods to exploit these observations are provided and include respecifiying non-cardiac cells into cardiac cells, stimulating cardiac tissue regeneration, and methods for treating cardiomyopathies, myocardial infarction.
REFERENCES:
patent: 5792453 (1998-08-01), Hammond et al.
patent: 6100242 (2000-08-01), Hammond et al.
patent: 6569662 (2003-05-01), Tang et al.
GenBank Accession No. AQ028029.
Edmonson et al., “Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis,”Development, 120:1251-1263, 1994.
GenBank Accession No. AC005358.
GenBank Accession No. AI607474.
GenBank Accession No. AW500597.
GenBank Accession No. BE311634.
Hammond et al., “Adenoviral based in-vivo gene transfer in the pig,”Clin. Res., 42:123A, 1994.
Harvey, “Nk-2 homeobox genes and heart development,”Dev. Biol., 178:203-216, 1996.
Kodama, et al., “Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes,”Cir. Res.81:656-663, 1997.
Leor et al., “Transplantation of fetal myocardial tissue into the infarcated myocardium of rat,”Circulation, 94(Suppl. II):II-332-II-336, 1996.
Lin et al., “Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C,”Science, 276:1404-1407, 1997.
Makino et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,”J. Clin. Invest., 103:697-105, 1999.
Molkentin, “Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins,”Cell, 83:1125-1136, 1995.
Pan, et al., “Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart,”Circ. Res., 81:611-617, 1997.
Srivastava et al., “A subclass of bHLH proteins required for cardiac morphogenesis,”Science, 270:1995-1999, 1995.
Aravind and Koonin, “SAP—a putative DNA-binding motif involved in chromosomal organization,”TIBS, 25:112-114, 2000.
Belaguli et al., “Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators,”Mol. Cell. Biol., 20:7550-7558, 2000.
EMBL Database Accession No. AF384055.
EMBL Database Accession No. AF532596.
Treisman, “Ternary complex factors: growth factor regulated transcriptional activators,”Curr. Opinion in Genetics and Development, 4:96-101, 1994.
Wang et al., “Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor,”Cell, 105:851-562, 2001.
Wang et al., “Potentiation of serum response factor activity by a family of myocardin-related transcription factors,”Proc. Natl. Acad. Sci., USA, 99:14855-14860, 2002.
Olson Eric N.
Wang Da-Zhi
Board of Regents , The University of Texas System
Fulbright & Jaworski LLP
Wax Robert A.
LandOfFree
Methods and compositions relating to a cardiac-specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions relating to a cardiac-specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions relating to a cardiac-specific... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3502773